MODIFICATION OF THE MIGRATION OF MOUSE LYMPHOID CELLS BY BCG: A FACTOR STIMULATING T-CELL MIGRATIONCASTES M; BORDERIE N; ORBACH ARBOUYS S et al.1978; CELL. IMMUNOL.; USA; DA. 1978; VOL. 40; NO 1; PP. 37-45; BIBL. 22 REF.Article

POSSIBLE ROLE OF MACROPHAGE-LIKE SUPPRESSOR CELLS IN THE ANTI-TUMOUR ACTIVITY OF BCGCASTES M; LYNCH NR; LESPINATS G et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 6; PP. 828-837; BIBL. 38 REF.Article

CHARACTERIZATION OF THE CELLULAR IMMUNE RESPONSE IN AMERICAN CUTANEOUS LEISHMANIASISCASTES M; AGNELLI A; VERDE O et al.1983; CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY; ISSN 0090-1229; USA; DA. 1983; VOL. 27; NO 2; PP. 176-186; BIBL. 34 REF.Article

MECHANISM OF INHIBITION OF TUMOUR GROWTH BY ASPIRIN AND INDOMETHACINLYNCH NR; CASTES M; ASTOIN M et al.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 38; NO 4; PP. 503-512; BIBL. 25 REF.Article

Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in Chagas' disease patientsCASTES, M; PANAGIOTOPOULOS, A; MOSCA, W et al.Immunopharmacology (New York). 1986, Vol 12, Num 3, pp 203-212, issn 0162-3109Article

Characterization of the cellular immune response in Chagas disease patientsCASTES, M; ARAUJO, Z; MOSCA, W et al.Acta cientifica Venezolana. 1986, Vol 37, Num 5, pp 547-553, issn 0001-5504Article

Mechanisms associated with immunoregulation in human American cutaneous leishmaniasisCASTES, M; AGNELLI, A; RONDON, A. J et al.Clinical and experimental immunology (Print). 1984, Vol 57, Num 2, pp 279-286, issn 0009-9104Article

T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasisCASTES, M; CABRERA, M; TRUJILLO, D et al.Journal of clinical microbiology (Print). 1988, Vol 26, Num 6, pp 1207-1213, issn 0095-1137Article

Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapyCASTES, M; MOROS, Z; MARTINEZ, A et al.Parasite immunology. 1989, Vol 11, Num 3, pp 211-222, issn 0141-9838Article

In situ characterization of the cellular immune response in American cutaneous leishmaniasisMODLIN, R. L; TAPIA, F. J; BLOOM, B. R et al.Clinical and experimental immunology (Print). 1985, Vol 60, Num 2, pp 241-248, issn 0009-9104Article

Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-γ responseARAUJO, Z; EL BOUHDIDI, A; HEREMANS, H et al.Vaccine. 1999, Vol 17, Num 7-8, pp 957-964, issn 0264-410XArticle

Leishmania colombiensis in VenezuelaDELGADO, O; CASTES, M; WHITE, A. C et al.The American journal of tropical medicine and hygiene. 1993, Vol 48, Num 1, pp 145-147, issn 0002-9637Article

Estudio de los aspectos epidemiológicos y socioeconómicos en mujeres con Leishmaniasis : Mujer y Sociedad = Etude des aspects épidémiologiques et socioéconomiques chez les femmes atteintes de Leishmaniasis : Femme et société = Study of epidemiological and socioeconomic aspects among women with LeishmaniasisCASTES, M; JIMENEZ, M; CASTANEDA, N et al.Fermentum. 1992, Num 4, pp 85-98Article

Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes : antibody responses to mycobacterial and leishmanial antigensSHARPLES, C. E; SHAW, M.-A; CASTES, M et al.Vaccine. 1994, Vol 12, Num 15, pp 1402-1412, issn 0264-410XArticle

The clinical and immunological spectrum of American cutaneous leishmaniasisCONVIT, J; ULRICH, M; FERNANDEZ, C. T et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993, Vol 87, Num 4, pp 444-448, issn 0035-9203Conference Paper

Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasisCONVIT, J; CASTELLANOS, P. L; BRETANA, A et al.The Journal of infectious diseases. 1989, Vol 160, Num 1, pp 104-115, issn 0022-1899Article

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasisCONVIT, J; RONDON, A; ULRICH, M et al.Lancet (British edition). 1987, Vol 1, Num 8530, pp 401-405, issn 0140-6736Article

Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-γ productionCASTES, M; BLACKWELL, J; TRUJILLO, D et al.Vaccine. 1994, Vol 12, Num 11, pp 1041-1051, issn 0264-410XArticle

Evaluation of serum levels of tumour necrosis factor-alpha (TNF-α) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatmentSANTANA-BLANK, L. A; CASTES, M; ROJAS, M. E et al.Clinical and experimental immunology (Print). 1992, Vol 90, Num 1, pp 43-48, issn 0009-9104Article

Demonstration of an indomethacin-sensitive mechanism regulating immune reactivity in American cutaneous leishmaniasis patientsCASTES, M; TRUJILLO, D; SCOTT, D et al.Clinical and experimental immunology (Print). 1987, Vol 69, Num 2, pp 280-290, issn 0009-9104Article

IFN-y, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected miceARAUJO, Z; HEREMANS, H; STORDEUR, P et al.Vaccine. 2000, Vol 18, Num 17, pp 1822-1829, issn 0264-410XArticle

Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infectionCLINTON WITHE, A. JR; CASTES, M; GARCIA, L et al.The American journal of tropical medicine and hygiene. 1992, Vol 46, Num 2, pp 123-131, issn 0002-9637Article

Evaluation of the interaction of leucocytes from chagas disease patients with trypomastigotes of Trypanosoma cruziMOSCA, W; CASTES, M; OJEDA, A et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1986, Vol 80, Num 6, pp 975-977, issn 0035-9203Article